DUBLIN--(BUSINESS WIRE)--The "Monoclonal
Antibody Therapeutics Market by Application, by Source and by End Users:
Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 -
2023" report has been added to ResearchAndMarkets.com's
offering.
The report covers forecast and analysis for the monoclonal antibody
therapeutics market on a global and regional level. The study provides
historic data of 2015 to 2017 along with a forecast from 2018 to 2023
based on revenue (USD Billion).
The study includes drivers and restraints for the monoclonal antibody
therapeutics market along with the impact they have on the demand over
the forecast period. Additionally, the report includes the study of
opportunities available in the monoclonal antibody therapeutics market
on a global level.
The study provides a decisive view on the monoclonal antibody
therapeutics market by segmenting the market based on application,
source, end user and region. All the segments have been analyzed based
on present and future trends and the market is estimated from 2018 to
2023.
Based on application, the market is segmented into cancer, autoimmune
diseases, infection, hematological diseases, and others. By source, the
market is segmented into human, humanized, chimeric and others. Based on
end users, the market is segmented into hospitals, private clinics and
research institutes.
The regional segmentation includes the current and forecast demand for
North America, Europe, Asia Pacific, Latin America and Middle East
Africa with its further bifurcation into major countries including the
U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This
segmentation includes demand for monoclonal antibody therapeutics market
based on all segments in all the regions and countries.
Market Dynamics Drivers
-
Growing Monoclonal Antibody Therapeutics Consumption in Developing
Countries
-
Changing Consumption Habits of Monoclonal Antibody Therapeutics
Restraints
-
High Taxation in Monoclonal Antibody Therapeutics Business and Trade
Opportunities
-
Innovative Products With Flavored Monoclonal Antibody Therapeutics
Key Topics Covered
1. Introduction
2. Executive Summary
3. Monoclonal Antibody Therapeutics Market - Market Dynamics
4. Global Monoclonal Antibody Therapeutics Market - Competitive Landscape
5. Global Monoclonal Antibody Therapeutics Market - Application Segment
Analysis
6. Global Monoclonal Antibody Therapeutics Market - Source Segment
Analysis
7. Global Monoclonal Antibody Therapeutics Market - End User Segment
Analysis
8. Global Monoclonal Antibody Therapeutics Market - Regional Segment
Analysis
9. Company Profiles
-
Pfizer Inc.
-
Bayer AG
-
Sanofi
-
Merck Co. Inc.
-
GlaxoSmithKline PLC
-
F. Hoffmann-La Roche Ltd.
-
Novartis AG
-
AbbVie Inc.
For more information about this report visit https://www.researchandmarkets.com/research/nf4w7r/monoclonal?w=4
